| Common Stock, Shares Authorized |
500,000,000 |
shares |
|
Q2 2025 |
|
| Common Stock, Shares, Issued |
13,500,000 |
shares |
|
Q2 2025 |
|
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$5,295,704 |
USD |
|
Q2 2025 |
|
| Deferred Tax Assets, Valuation Allowance |
$205,788 |
USD |
|
Q2 2025 |
|
| Operating Lease, Liability |
$271,831 |
USD |
|
Q2 2025 |
|
| Lessee, Operating Lease, Liability, to be Paid |
$273,600 |
USD |
|
Q2 2025 |
|
| Property, Plant and Equipment, Gross |
$4,586,072 |
USD |
|
Q2 2025 |
|
| Operating Lease, Liability, Current |
$271,831 |
USD |
|
Q2 2025 |
|
| Lessee, Operating Lease, Liability, to be Paid, Year One |
S$360,000 |
SGD |
|
Q2 2025 |
|
| Operating Lease, Weighted Average Discount Rate, Percent |
0.02 |
pure |
|
Q4 2024 |
|
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$1,769 |
USD |
|
Q2 2025 |
|
| Deferred Tax Assets, Operating Loss Carryforwards |
$25,618 |
USD |
|
Q2 2025 |
|
| Unrecognized Tax Benefits |
S$0 |
SGD |
|
Q2 2025 |
|
| Additional Paid in Capital |
$6,057,736 |
USD |
|
Q2 2025 |
|
| Deferred Tax Assets, Net of Valuation Allowance |
$277,617 |
USD |
|
Q2 2025 |
|